The store will not work correctly when cookies are disabled.
2-(Benzimidazol-2-yl)-3-(5-bromothiophen-3-yl)-acrylonitrile
ID: ALA455419
PubChem CID: 25111454
Max Phase: Preclinical
Molecular Formula: C14H8BrN3S
Molecular Weight: 330.21
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1csc(Br)c1)c1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C14H8BrN3S/c15-13-6-9(8-19-13)5-10(7-16)14-17-11-3-1-2-4-12(11)18-14/h1-6,8H,(H,17,18)/b10-5+
Standard InChI Key: WGYDWSQCRFHYGF-BJMVGYQFSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
10.4569 -3.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4557 -3.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1706 -4.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1688 -2.7080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8841 -3.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8844 -3.9482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6749 -4.2048 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1632 -3.5323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6744 -2.8602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9882 -3.5320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4009 -4.2463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4004 -2.8174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8083 -2.1000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2259 -4.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7069 -4.9150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4915 -4.6598 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.4912 -3.8347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7065 -3.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1584 -3.3495 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
9 5 1 0
4 1 1 0
8 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 1 0
12 13 3 0
3 6 2 0
11 14 1 0
14 15 2 0
1 2 2 0
5 4 2 0
6 7 1 0
7 8 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
8 9 2 0
17 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.21 | Molecular Weight (Monoisotopic): 328.9622 | AlogP: 4.45 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.47 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.53 | CX Basic pKa: 3.64 | CX LogP: 4.41 | CX LogD: 4.41 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.71 | Np Likeness Score: -1.94 |
References
1. Saczewski F, Stencel A, Bieńczak AM, Langowska KA, Michaelis M, Werel W, Hałasa R, Reszka P, Bednarski PJ.. (2008) Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents., 43 (9): [PMID:18187237] [10.1016/j.ejmech.2007.11.017] |